Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 2
1995 1
1996 4
1997 2
1998 1
1999 5
2000 6
2001 6
2003 6
2004 6
2005 1
2006 4
2007 2
2008 3
2009 4
2010 1
2011 3
2012 5
2013 9
2014 5
2015 10
2016 6
2017 6
2018 4
2019 9
2020 6
2021 11
2022 6
2023 2
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Results by year

Filters applied: . Clear all
Page 1
Macitentan and morbidity and mortality in pulmonary arterial hypertension.
Pulido T, Adzerikho I, Channick RN, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Jing ZC, Le Brun FO, Mehta S, Mittelholzer CM, Perchenet L, Sastry BK, Sitbon O, Souza R, Torbicki A, Zeng X, Rubin LJ, Simonneau G; SERAPHIN Investigators. Pulido T, et al. Among authors: channick rn. N Engl J Med. 2013 Aug 29;369(9):809-18. doi: 10.1056/NEJMoa1213917. N Engl J Med. 2013. PMID: 23984728 Free article. Clinical Trial.
Risk stratification and medical therapy of pulmonary arterial hypertension.
Galiè N, Channick RN, Frantz RP, Grünig E, Jing ZC, Moiseeva O, Preston IR, Pulido T, Safdar Z, Tamura Y, McLaughlin VV. Galiè N, et al. Among authors: channick rn. Eur Respir J. 2019 Jan 24;53(1):1801889. doi: 10.1183/13993003.01889-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30545971 Free PMC article. Review.
Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial.
Frantz RP, McLaughlin VV, Sahay S, Escribano Subías P, Zolty RL, Benza RL, Channick RN, Chin KM, Hemnes AR, Howard LS, Sitbon O, Vachiéry JL, Zamanian RT, Cravets M, Roscigno RF, Mottola D, Osterhout R, Bruey JM, Elman E, Tompkins CA, Parsley E, Aranda R, Zisman LS, Ghofrani HA; TORREY Study Investigators. Frantz RP, et al. Among authors: channick rn. Lancet Respir Med. 2024 Jul;12(7):523-534. doi: 10.1016/S2213-2600(24)00072-9. Epub 2024 May 2. Lancet Respir Med. 2024. PMID: 38705167 Clinical Trial.
Rebuttal From Drs Channick and Saggar.
Channick RN, Saggar R. Channick RN, et al. Chest. 2019 Dec;156(6):1047-1048. doi: 10.1016/j.chest.2019.07.006. Chest. 2019. PMID: 31812191 No abstract available.
Pulmonary hypertension.
Humbert M, Channick RN. Humbert M, et al. Among authors: channick rn. Curr Opin Pulm Med. 2016 Sep;22(5):399. doi: 10.1097/MCP.0000000000000309. Curr Opin Pulm Med. 2016. PMID: 27428648 No abstract available.
Post-Intensive Care Unit Follow-up of Pulmonary Embolism.
Jasuja S, Channick RN. Jasuja S, et al. Among authors: channick rn. Crit Care Clin. 2020 Jul;36(3):561-570. doi: 10.1016/j.ccc.2020.03.002. Epub 2020 May 11. Crit Care Clin. 2020. PMID: 32473699 Review.
Sex Differences in Portopulmonary Hypertension.
DuBrock HM, Cartin-Ceba R, Channick RN, Kawut SM, Krowka MJ. DuBrock HM, et al. Among authors: channick rn. Chest. 2021 Jan;159(1):328-336. doi: 10.1016/j.chest.2020.07.081. Epub 2020 Aug 13. Chest. 2021. PMID: 32798521 Free PMC article.
131 results